ACE inhibitors – enalapril, lisinopril, quinapril and an equivalent dose of a different ACE inhibitor or added to quinapril (or an alternative ACE inhibitor)
Our results suggest that enalapril, lisinopril, and ramipril are equally effective in the treatment of patients with HFrEF when given at equivalent doses. Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study
For example, daily doses of 10 mg ramipril, 20 mg enalapril or 20 mg lisinopril were considered as 100% dose equivalent, while 5 mg ramipril, 10 mg enalapril or 10 mg lisinopril were defined as 50% dose equivalent.
Our results suggest that enalapril, lisinopril, and ramipril are equally effective in the treatment of patients with HFrEF when given at equivalent doses. Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study
For example, daily doses of 10 mg ramipril, 20 mg enalapril or 20 mg lisinopril were considered as 100% dose equivalent, while 5 mg ramipril, 10 mg enalapril or 10 mg lisinopril were defined as 50% dose equivalent.
Lisinopril, Perindopril, Quinalapril, Ramipril, Trandolapril. - Select active agent 2 -, Benazepril, Captopril, Cilazapril, Enalapril Dose in mg, Equivalent
enalapril, lisinopril (captopril, enalapril, lisinopril, and trandolapril) and placebo, enalapril significantly reduced followed a similar
It is suggested that enalapril, lisinopril, and ramipril are equally effective in the treatment of patients with HFrEF when given at equivalent doses.
Our results suggest that enalapril, lisinopril, and ramipril are equally effective in the treatment of patients with HFrEF when given at equivalent doses. Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study
Comments